Pricing
Login
Home
Charts
Search
Watchlist
Products

Astal Laboratories Ltd

ASTALLTD
₹58.67-0.74%20 Nov 2026
Reports
Pharma API

Astal Laboratories Ltd

ASTALLTD
₹58.67
-0.74%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹257Cr
Close
Close Price
₹58.67
Industry
Industry
Pharma API
PE
Price To Earnings
6.78
PS
Price To Sales
0.65
Revenue
Revenue
₹395Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
233852134101108
Growth YoY
Revenue Growth YoY%
471.1187.7
Expenses
ExpensesCr
1934491248991
Operating Profit
Operating ProfitCr
444101217
OPM
OPM%
17.810.36.87.612.116.0
Other Income
Other IncomeCr
000000
Interest Expense
Interest ExpenseCr
000111
Depreciation
DepreciationCr
000111
PBT
PBTCr
43381015
Tax
TaxCr
111116
PAT
PATCr
3328910
Growth YoY
PAT Growth YoY%
180.3278.7
NPM
NPM%
11.76.94.55.79.39.1
EPS
EPS₹
2.82.42.22.02.22.2
QuarterMar 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
233852134101108
Growth YoY
Revenue Growth YoY%
471.1187.7
Expenses
ExpensesCr
1934491248991
Operating Profit
Operating ProfitCr
444101217
OPM
OPM%
17.810.36.87.612.116.0
Other Income
Other IncomeCr
000000
Interest Expense
Interest ExpenseCr
000111
Depreciation
DepreciationCr
000111
PBT
PBTCr
43381015
Tax
TaxCr
111116
PAT
PATCr
3328910
Growth YoY
PAT Growth YoY%
180.3278.7
NPM
NPM%
11.76.94.55.79.39.1
EPS
EPS₹
2.82.42.22.02.22.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
64250395
Growth
Revenue Growth%
289.4
Expenses
ExpensesCr
51229352
Operating Profit
Operating ProfitCr
132143
OPM
OPM%
19.98.310.9
Other Income
Other IncomeCr
001
Interest Expense
Interest ExpenseCr
124
Depreciation
DepreciationCr
013
PBT
PBTCr
121837
Tax
TaxCr
338
PAT
PATCr
91529
Growth
PAT Growth%
64.8
NPM
NPM%
13.95.97.4
EPS
EPS₹
9.14.88.7
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
64250395
Growth
Revenue Growth%
289.4
Expenses
ExpensesCr
51229352
Operating Profit
Operating ProfitCr
132143
OPM
OPM%
19.98.310.9
Other Income
Other IncomeCr
001
Interest Expense
Interest ExpenseCr
124
Depreciation
DepreciationCr
013
PBT
PBTCr
121837
Tax
TaxCr
338
PAT
PATCr
91529
Growth
PAT Growth%
64.8
NPM
NPM%
13.95.97.4
EPS
EPS₹
9.14.88.7
Sales CAGR
1 Year289%
3 Years-
5 Years-
TTM-
EBITDA CAGR
1 Year63%
3 Years-
5 Years-
TTM-
PAT CAGR
1 Year65%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year5%
3 Years-
5 Years-
TTM10%
CFO / EBITDA
1 Year-85%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
104244
Reserves
ReservesCr
22289314
Current Liabilities
Current LiabilitiesCr
27165169
Non Current Liabilities
Non Current LiabilitiesCr
12021
Total Liabilities
Total LiabilitiesCr
63519547
Current Assets
Current AssetsCr
46243273
Non Current Assets
Non Current AssetsCr
18276274
Total Assets
Total AssetsCr
63519547
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
104244
Reserves
ReservesCr
22289314
Current Liabilities
Current LiabilitiesCr
27165169
Non Current Liabilities
Non Current LiabilitiesCr
12021
Total Liabilities
Total LiabilitiesCr
63519547
Current Assets
Current AssetsCr
46243273
Non Current Assets
Non Current AssetsCr
18276274
Total Assets
Total AssetsCr
63519547

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13-18
Investing Cash Flow
Investing Cash FlowCr
-8-2
Financing Cash Flow
Financing Cash FlowCr
33
Net Cash Flow
Net Cash FlowCr
-17-17
Free Cash Flow
Free Cash FlowCr
-18-19
CFO To PAT
CFO To PAT%
-140.3-120.3
CFO To EBITDA
CFO To EBITDA%
-98.0-85.2
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-13-18
Investing Cash Flow
Investing Cash FlowCr
-8-2
Financing Cash Flow
Financing Cash FlowCr
33
Net Cash Flow
Net Cash FlowCr
-17-17
Free Cash Flow
Free Cash FlowCr
-18-19
CFO To PAT
CFO To PAT%
-140.3-120.3
CFO To EBITDA
CFO To EBITDA%
-98.0-85.2

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
75276257
Price To Earnings
Price To Earnings
8.418.86.8
Price To Sales
Price To Sales
1.21.10.7
Price To Book
Price To Book
2.30.80.7
EV To EBITDA
EV To EBITDA
6.815.67.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.311.411.4
OPM
OPM%
19.98.310.9
NPM
NPM%
13.95.97.4
ROCE
ROCE%
27.85.210.0
ROE
ROE%
27.74.48.2
ROA
ROA%
14.12.85.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
75276257
Price To Earnings
Price To Earnings
8.418.86.8
Price To Sales
Price To Sales
1.21.10.7
Price To Book
Price To Book
2.30.80.7
EV To EBITDA
EV To EBITDA
6.815.67.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.311.411.4
OPM
OPM%
19.98.310.9
NPM
NPM%
13.95.97.4
ROCE
ROCE%
27.85.210.0
ROE
ROE%
27.74.48.2
ROA
ROA%
14.12.85.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr62751548725719116344
Close PriceClose₹179.3794.911,610.8058.679.8130.4627.55
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE11.1331.7437.596.7821.60
Price To SalesPS0.931.371.460.65109.520.280.17
RevenueRevenueCr6763773343952583262
Revenue Growth TTMRev Gr TTM%7.5%102.4%-1.0%-70.8%42.4%-2.3%
PAT Growth TTMPAT Gr TTM%4.8%219.7%-44.7%81.7%35.8%-92.5%
Market CapitalizationMkt CapCr62751548725719116344
Close PriceClose₹179.3794.911,610.8058.679.8130.4627.55
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE11.1331.7437.596.7821.60
Price To SalesPS0.931.371.460.65109.520.280.17
RevenueRevenueCr6763773343952583262
Revenue Growth TTMRev Gr TTM%7.5%102.4%-1.0%-70.8%42.4%-2.3%
PAT Growth TTMPAT Gr TTM%4.8%219.7%-44.7%81.7%35.8%-92.5%
Annual Reports
FY2026
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews